increase with coffee

Sophia Antipolis, September 27, 2022: Drinking two to three cups of coffee a day was associated with a longer life and a lower risk of cardiovascular disease compared to no coffee. European Journal of Preventive Cardiology, Journal of ESC.¹ Findings were applied to powdered, instant and decaffeinated varieties.

“In this large observational study, ground coffee, instant coffee, and decaffeinated coffee were associated with comparable reductions in cardiovascular disease incidence and mortality from cardiovascular disease or other causes. ,” said study author Professor Peter Kistler of the Baker Heart and Diabetes Institute. Melbourne, Australia. “The results suggest that light to moderate consumption of ground coffee, instant coffee and decaffeinated coffee should be considered part of a healthy lifestyle.”

Little information is available on the effects of different coffee preparations on heart health and survival. We examined associations with arrhythmias, cardiovascular disease, and mortality. Cardiovascular disease includes coronary heart disease, congestive heart failure, and ischemic stroke.

The study included 449,563 participants without arrhythmia or other cardiovascular disease at baseline. The median age he was 58 years old and 55.3% were female. Participants completed a questionnaire asking how many cups of coffee they drank each day and whether they usually drank instant coffee, ground coffee (such as cappuccino or filter coffee), or decaffeinated coffee. They were then grouped into six daily intake categories: none, less than 1 cup, 1 cup, 2-3 cups, 4-5 cups, and more than 5 cups per day. 198,062 (44.1%) were instant, 82,575 (18.4%) were ground, and 68,416 (15.2%) were decaffeinated. He was 100,510 (22.4%) who did not drink coffee and served as a control group.

After adjusting for age, sex, race, obesity, hypertension, diabetes, obstructive sleep apnea, smoking status, and tea and alcohol intake, coffee consumption was significantly correlated with the incidence of cardiac arrhythmias, cardiovascular disease, and death. Drinkers were compared to non-drinkers. Outcome information was obtained from medical and death records. His median follow-up was 12.5 years.

A total of 27,809 (6.2%) participants died during follow-up. All types of coffee were associated with a reduction in all-cause mortality. Decaffeinated, ground, and ready-to-eat foods were associated with 14%, 27%, and 11% lower mortality, respectively.

Cardiovascular disease was diagnosed in 43,173 (9.6%) participants during follow-up. All coffee subtypes were associated with reduced incidence of cardiovascular disease. Again, the lowest risk was with 2-3 cups of coffee per day, and the potential for cardiovascular disease with decaffeinated, ground, and instant coffee compared with abstinence. sex decreased by 6%, 20%, and 9%, respectively.

Arrhythmia was diagnosed in 30,100 (6.7%) participants during follow-up. Ground and instant coffee, but not decaffeination, were associated with reduced cardiac arrhythmias, including atrial fibrillation. had the lowest risk with 2-3 drinks per day, reducing risk by 17% and 12%, respectively.

Professor Kistler said: Non-caffeinated compounds may have been involved in the observed positive relationship between coffee drinking, cardiovascular disease and survival. It shows that drinking should not be discouraged and can be enjoyed as a heart-healthy behavior.

end

author: ESC Press Office
Mobile: +33 (0)7 8531 2036
Email: [email protected]

follow me on twitter @ESCardio News

Funding: None.

Disclosure: see the paper.

References

¹Chieng D, Canovas R, Segan L, othersEffect of coffee subtypes on developing cardiovascular disease, arrhythmias, and mortality: long-term results from the UK Biobank. Cardiol before Eur J2022. doi:10.1093/eurjpc/zwac189.

Links will be published when published:

https://academic.oup.com/eurjpc/article-lookup/doi/10.1093/eurjpc/zwac189

About the European College of Cardiology

The European Society of Cardiology brings together medical professionals from more than 150 countries to advance cardiovascular medicine and help people live longer, healthier lives.

regarding European Journal of Preventive Cardiology
of European Journal of Preventive Cardiology is the world’s leading journal of preventive cardiology and plays a pivotal role in reducing the global burden of cardiovascular disease.

Disclaimer: AAAS and EurekAlert! EurekAlert! is not responsible for the accuracy of news releases posted. Use of information by contributors or via the EurekAlert system.